South Dakota Medicaid and tirzepatide
Zepbound for weight loss: no. Agents used for weight loss are not covered. No Zepbound form could be read, so other covered uses were not confirmed. Mounjaro for weight loss: no; for type 2 diabetes South Dakota Medicaid must cover it. Read from South Dakota Department of Social Services, Division of Medicaid documents Nov 6, 2026.
In 2025 South Dakota Medicaid paid for 7,486 tirzepatide prescriptions (Mounjaro), 48% of its GLP-1 prescriptions and 38th of the 50 states and DC. It reimbursed $7.7 million before rebates, $1,023 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Mounjaro | 7,486 | $7.7 million | $1,023 |
Tirzepatide in the states around South Dakota
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| South Dakota | 17 | $69/moWellmedr | 7,486 | Medicaid Zepbound: No |
| Iowa | 17 | $69/moWellmedr | 22,499 | Medicaid Zepbound: No |
| Minnesota | 17 | $69/moWellmedr | 49,251 | Medicaid Zepbound: Yes |
| Montana | 17 | $69/moWellmedr | 2,904 | Medicaid Zepbound: No |
| Nebraska | 17 | $69/moWellmedr | 6,041 | Medicaid Zepbound: No |
| North Dakota | 15 | $69/moWellmedr | 67 | Medicaid Zepbound: No |
| Wyoming | 17 | $69/moWellmedr | 738 | Medicaid Zepbound: No |



